Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

SHA:600332 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40,687	43,716	44,550	46,355	52,103	44,644
Market Cap Growth	-1.87%	-1.87%	-3.90%	-11.03%	16.71%	-19.26%
Enterprise Value	33,781	42,017	38,768	38,568	41,153	36,537
Last Close Price	26.46	28.42	27.51	28.02	31.46	26.42
PE Ratio	14.35	15.42	10.99	11.69	14.01	15.31
PS Ratio	0.58	0.58	0.59	0.66	0.76	0.72
PB Ratio	1.16	1.16	1.22	1.38	1.66	1.58
P/TBV Ratio	1.36	1.36	1.43	1.62	2.03	1.95
P/FCF Ratio	18.89	18.89	18.00	8.26	11.79	-
P/OCF Ratio	12.70	12.70	10.86	6.62	9.18	76.29
EV/Sales Ratio	0.45	0.56	0.51	0.55	0.60	0.59
EV/EBITDA Ratio	7.90	10.33	7.10	7.71	9.37	10.70
EV/EBIT Ratio	9.80	12.10	8.08	8.60	10.37	12.07
EV/FCF Ratio	14.60	18.16	15.66	6.87	9.31	-
Debt / Equity Ratio	0.37	0.37	0.33	0.36	0.32	0.34
Debt / EBITDA Ratio	3.23	3.23	2.09	2.30	2.14	2.60
Debt / FCF Ratio	6.01	6.01	4.83	2.14	2.25	-
Asset Turnover	0.94	0.94	0.99	1.01	1.10	1.06
Inventory Turnover	5.14	5.14	5.53	5.45	5.53	5.33
Quick Ratio	1.11	1.11	1.17	1.20	1.27	1.23
Current Ratio	1.48	1.48	1.55	1.53	1.64	1.62
Return on Equity (ROE)	8.06%	8.06%	12.12%	13.09%	13.33%	11.41%
Return on Assets (ROA)	2.71%	2.71%	3.91%	3.98%	3.94%	3.24%
Return on Capital (ROIC)	4.33%	4.33%	6.36%	6.45%	6.28%	5.37%
Return on Capital Employed (ROCE)	8.10%	8.10%	11.30%	12.00%	11.70%	9.90%
Earnings Yield	6.97%	6.49%	9.10%	8.56%	7.14%	6.53%
FCF Yield	5.69%	5.29%	5.56%	12.11%	8.48%	-0.65%
Dividend Yield	4.26%	2.81%	2.72%	2.61%	2.18%	2.04%
Payout Ratio	79.38%	79.38%	39.09%	37.58%	34.03%	44.25%
Buyback Yield / Dilution	-0.02%	-0.02%	0.02%	-	-	-
Total Shareholder Return	4.27%	2.79%	2.74%	2.61%	2.18%	2.04%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.